Saniona Files FDA IND for SAN2465 in Major Depressive Disorder
Saniona submitted an IND to the FDA for SAN2465. A Phase 1 study in healthy volunteers is expected to begin by the end of 2026, contingent on FDA clearance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.